4.6 Article

Regulation of Interleukin-8 Gene at a Distinct Site of Its Promoter by CCAAT Enhancer-binding Protein Homologous Protein in Prostaglandin E2-treated Human T Cells

Journal

JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 283, Issue 44, Pages 29760-29769

Publisher

AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M803145200

Keywords

-

Funding

  1. Dottorato di Ricerca in Patologia della proliferazione cellulare e del differenziamento
  2. Progetto di Ricerca di Ateneo
  3. School of Specialization in Clinical Pathology (University of Messina)

Ask authors/readers for more resources

For a long period of time, the transcription factor CCAAT/enhancer-binding protein homologous protein (CHOP) has been thought to inhibit transcriptional activity for its ability to interact with CCAAT enhancer-binding protein family factors, thus preventing their binding to DNA. We have previously shown that in human T lymphocytes the CHOP phosphorylation induced by prostaglandin E-2 (PGE(2))-increased interleukin-8 ( IL-8) gene expression. Given the CHOP positive role in the regulation of transcription, here we have investigated the molecular mechanism(s) by which CHOP increases IL-8 gene activity under PGE2 stimulus. Transfection experiments with mutants showed both that the CHOP transactivation domain is essential for IL-8 transcription and that the IL-8/activator protein 1 (AP-1) promoter mutated in NF-kappa B and NF-IL-6, but not in the AP-1 site, harbors essential CHOP-responsive elements. CHOP silencing confirmed its role in the IL- 8 transcriptional regulation and protein production, whereas c-Jun small interfering RNA experiments showed that the PGE(2)-induced activation of IL- 8 promoter is mainly c-Jun-independent. Moreover, PGE2 induced CHOP-DNA complexes only when the entire IL-8/AP-1 promoter or the wild type sequences encompassing the AP-1 upstream region were employed. Mutations introduced in these sequences prevented the DNA-CHOP complex formation. The IL-8/AP-1 mutant promoter lacking the sequence immediately upstream the AP-1 site is PGE2-unresponsive. Finally, chromatin immunoprecipitation data confirmed in vivo that PGE2 induces CHOP binding to the IL- 8 promoter. Taken together, our results suggest that the increased expression of CHOP in response to PGE2 exerts a positive transcriptional regulation of the IL- 8 promoter mediated by direct binding to a novel consensus site.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Impact of acute inflammation on Band 3 protein anion exchange capability in human erythrocytes

Rossana Morabito, Alessia Remigante, Marika Cordaro, Vincenzo Trichilo, Saverio Loddo, Silvia Dossena, Angela Marino

Summary: This study found that acute inflammation affects the function of erythrocytes, leading to increased anion exchange capability of the Band 3 protein, increased lipid peroxidation, and decreased -SH groups and GSH content. Serum CRP level recovery is associated with the recovery of -SH groups and GSH, but not with the restoration of anion exchange capability. After 2 months, all parameters were completely recovered.

ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2022)

Article Biochemistry & Molecular Biology

Relevance of AIF/CypA Lethal Pathway in SH-SY5Y Cells Treated with Staurosporine

Mariarosaria Conte, Rosanna Palumbo, Alessandra Monti, Elisabetta Fontana, Angela Nebbioso, Menotti Ruvo, Lucia Altucci, Nunzianna Doti

Summary: The AIF/CypA complex has lethal activity in rodent models of acute brain injury, but an AIF peptide has been found to restore cell survival and prevent brain injury. This study shows that the peptide can also protect against apoptosis in PD cells, suggesting the AIF/CypA complex as a potential target for developing new PD therapies.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemistry & Molecular Biology

Discovery of a new class of triazole based inhibitors of acetyl transferase KAT2A

Roberta Pacifico, Nunzio Del Gaudio, Guglielmo Bove, Lucia Altucci, Lydia Siragusa, Gabriele Cruciani, Menotti Ruvo, Rosa Bellavita, Paolo Grieco, Mauro F. A. Adamo

Summary: We have developed a synthetic method to produce two types of triazole compounds. Through virtual screening and experimental validation, one of the triazole compounds showed specific binding and inhibition towards KAT2A, laying the foundation for a new class of KAT2A inhibitors.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2022)

Review Genetics & Heredity

BK Virus Infection and BK-Virus-Associated Nephropathy in Renal Transplant Recipients

Margherita Borriello, Diego Ingrosso, Alessandra Fortunata Perna, Angela Lombardi, Paolo Maggi, Lucia Altucci, Michele Caraglia

Summary: Poliomavirus BK virus (BKV) is a highly infective virus that can cause asymptomatic infections. In renal transplanted recipients, BKV can lead to severe complications. Current treatments and prophylaxis options are limited, but increasing surveillance and early diagnosis show promise in improving outcomes.

GENES (2022)

Article Biology

Biochemical reaction network topology defines dose-dependent Drug-Drug interactions

Mehrad Babaei, Tom M. J. Evers, Fereshteh Shokri, Lucia Altucci, Elizabeth C. M. de Lange, Alireza Mashaghi

Summary: Drug combination therapy is a promising strategy for enhanced therapeutic effects and reduced side effects. In this study, reaction network topology-guided design of combination therapy was investigated as a predictive in silico drug-drug interaction screening approach. The results revealed that drug-drug interactions are influenced by target arrangement, drug nature, and desired change in network output.

COMPUTERS IN BIOLOGY AND MEDICINE (2023)

Review Oncology

Interplay between m6A epitranscriptome and epigenome in cancer: current knowledge and therapeutic perspectives

Guglielmo Bove, Sajid Amin, Mehrad Babaei, Rosaria Benedetti, Angela Nebbioso, Lucia Altucci, Nunzio Del Gaudio

Summary: Chromatin has a flexible structure that allows for precise gene expression regulation. Epigenetic modifications and modifications on RNA and histone substrates play important roles in governing cellular functions and contribute to cancer development. The interplay between genetic mutations and reversible epigenetic alterations has been of great interest. The modification of the RNA code, such as m(6)A, affects the stability, metabolism, and life cycle of various mRNAs, including those associated with cancer. Epigenetic and epitranscriptomic pathways collectively control cellular expression profile and cell fate. The crosstalk between these two pathways has recently been revealed, uncovering previously unknown interactions. Dysregulation of this network has been implicated in cancer, adding a new layer of complexity to gene expression. This article summarizes the current understanding of the interplay between m(6)A epitranscriptome and epigenome, with a focus on cancer processes. Strategies to target the m(6)A machinery for future therapeutic intervention are also discussed.

INTERNATIONAL JOURNAL OF CANCER (2023)

Review Chemistry, Medicinal

Recent Advancement in Anticancer Compounds from Marine Organisms: Approval, Use and Bioinformatic Approaches to Predict New Targets

Giovanna Santaniello, Angela Nebbioso, Lucia Altucci, Mariarosaria Conte

Summary: In recent years, the study of anticancer bioactive compounds from marine sources has gained significant attention. Regulatory authorities have approved marine molecules and new synthetic derivatives for cancer treatment. However, the administration of drugs in cancer patients requires careful evaluation due to their interaction with biological macromolecules. The search for personalized therapies and advancements in tumor prevention has been aided by new knowledge on cancer mechanisms, but a definitive therapy for cancer is still being sought.

MARINE DRUGS (2023)

Article Oncology

Thyroid Cancer Persistence in Patients with Unreliable Thyroglobulin Measurement: Circulating microRNA as Candidate Alternative Biomarkers

Alfredo Campenni, M'hammed Aguennouz, Massimiliano Siracusa, Angela Alibrandi, Francesca Polito, Rosaria Oteri, Sergio Baldari, Rosaria Maddalena Ruggeri, Luca Giovanella

Summary: About 30% of patients with papillary thyroid cancer (PTC) experience persistent or recurrent disease within 10 years after initial treatment. However, the measurement of serum thyroglobulin (Tg) is unreliable in the presence of anti-thyroglobulin antibodies (TgAb). This pilot study investigated the potential of circulating miRNA as valuable biomarkers for the early detection of persistent disease in TgAb-positive PTC patients. The findings indicate that serum miRNA kinetics may provide additional and independent information for the early detection of persistent disease in PTC patients with uninformative Tg results.

CANCERS (2022)

Article Biochemistry & Molecular Biology

Functional Validation of the Putative Oncogenic Activity of PLAU

Federica Sarno, Desiree Goubert, Emilie Logie, Martijn G. S. Rutten, Mihaly Koncz, Christophe Deben, Anita E. Niemarkt, Lucia Altucci, Pernette J. Verschure, Antal Kiss, Wim Vanden Berghe, Marianne G. Rots

Summary: Plasminogen activator, urokinase (PLAU) plays a role in cell migration, proliferation, and tissue remodeling. Its upregulation is associated with increased aggressiveness and metastasis in various cancer types, including breast cancer. This study examined the effects of modulating PLAU expression on breast cancer cells using CRISPR-dCas9 tools, and found that it affected cell proliferation and metastatic properties.

BIOMEDICINES (2023)

Article Oncology

Targeting HDAC2-Mediated Immune Regulation to Overcome Therapeutic Resistance in Mutant Colorectal Cancer

Mariarosaria Conte, Annabella Di Mauro, Lucia Capasso, Liliana Montella, Mariacarla De Simone, Angela Nebbioso, Lucia Altucci

Summary: This study identified simultaneous alterations in HDAC2, CIITA, and B2M genes in colorectal cancer patients and explored their potential role in immune dysfunction. HDAC2 was found to be deregulated in a subset of patients, while CIITA had specific alterations. Correlations among these genes and differential infiltration levels suggested an indirect immune-related role of HDAC2 in specific immune infiltrates. Further immunological signature studies could provide valuable clinical information for resistant forms of colorectal cancer.

CANCERS (2023)

Review Cell Biology

Emerging Roles of SIRT5 in Metabolism, Cancer, and SARS-CoV-2 Infection

Emanuele Fabbrizi, Francesco Fiorentino, Vincenzo Carafa, Lucia Altucci, Antonello Mai, Dante Rotili

Summary: SIRT5, a mitochondrial enzyme, regulates cellular homeostasis and the activity of proteins involved in various metabolic pathways. It plays critical roles in myocardial energy metabolism, neurodegenerative disease protection, and tumor development. SIRT5 is also implicated in SARS-CoV-2 infection. This review discusses its molecular actions, effects on metabolic targets, potential as a therapeutic target, and currently reported modulators including activators and inhibitors.

CELLS (2023)

Review Cell Biology

HAT1: Landscape of Biological Function and Role in Cancer

Vincenza Capone, Laura Della Torre, Daniela Carannante, Mehrad Babaei, Lucia Altucci, Rosaria Benedetti, Vincenzo Carafa

Summary: Histone modifications play a crucial role in the pathogenesis of diseases, including cancer, and acetylation is a reversible epigenetic process with important functions in cell life. HAT1 has been found to regulate molecular pathways, including those involved in cancer. This review summarizes the current knowledge and recent advances of HAT1 in the pathogenesis of cancer.

CELLS (2023)

Article Biochemistry & Molecular Biology

Sirtuin Inhibitor Cambinol Induces Cell Differentiation and Differently Interferes with SIRT1 and 2 at the Substrate Binding Site

Deborah Giordano, Bernardina Scafuri, Luigi De Masi, Lucia Capasso, Viviana Maresca, Lucia Altucci, Angela Nebbioso, Angelo Facchiano, Paola Bontempo

Summary: This study aimed to investigate the effects of Cambinol and its underlying mechanisms on cell differentiation. The findings demonstrated that Cambinol induced differentiation in MCF-7, NB4, and 3T3-L1 cell lines by modulating the expression of cell cycle-related proteins and nuclear receptors. In addition, molecular simulations revealed that Cambinol showed inhibitory effects on human SIRT1 and SIRT2, with stronger interaction with the substrate binding site of SIRT1. Overall, Cambinol may serve as a potential alternative for epigenetic therapies targeting SIRTs.

BIOMEDICINES (2023)

Article Biochemistry & Molecular Biology

(+)-Lipoic Acid Reduces Lipotoxicity and Regulates Mitochondrial Homeostasis and Energy Balance in an In Vitro Model of Liver Steatosis

Lucia Longhitano, Alfio Distefano, Angela Maria Amorini, Laura Orlando, Sebastiano Giallongo, Daniele Tibullo, Giuseppe Lazzarino, Anna Nicolosi, Amer M. Alanazi, Concetta Saoca, Vincenzo Macaione, M'hammed Aguennouz, Federico Salomone, Emanuela Tropea, Ignazio Alberto Barbagallo, Giovanni Li Volti, Giacomo Lazzarino

Summary: This study aimed to investigate the effects of lipoic acid on lipotoxicity and mitochondrial dynamics in an in vitro model of liver steatosis. The results showed that lipoic acid treatment reduced lipotoxicity and improved mitochondrial functions, suggesting its potential as a pharmacological tool for NAFLD treatment.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

Epigenetic regulation of TP53 is involved in prostate cancer radioresistance and DNA damage response signaling

Catarina Macedo-Silva, Vera Miranda-Goncalves, Nuno Tiago Tavares, Daniela Barros-Silva, Joana Lencart, Joao Lobo, Angelo Oliveira, Margareta P. Correia, Lucia Altucci, Carmen Jeronimo

Summary: This study found that p53 is highly expressed in radioresistant prostate cancer cells and in prostate cancer patients with recurrence or disease progression after radiation therapy. Mechanistic analysis showed that radiation therapy can promote p53 expression through epigenetic modulation. Inhibition of KDM6B decreased p53 expression and attenuated the radioresistant phenotype of prostate cancer cells.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2023)

No Data Available